Bacterin's OsteoSelectA DBM Putty Approved for Spinal Fusion Applications

Bacterin International Holdings, Inc. , a leader in the development of revolutionary bone graft material and coatings for medical applications, is pleased to announce it has obtained 510 approval to market OsteoSelectA DBM Putty for use in spinal fusion procedures.

http://www.businesswire.com/portal/site/topix/index.jsp?ndmViewId=news_view&newsId=20130716005742&newsLang=en&ndmConfigId=1000639&vnsId=41